51
Participants
Start Date
August 9, 2021
Primary Completion Date
March 31, 2026
Study Completion Date
March 31, 2026
Biopsy Procedure
Undergo tissue biopsy
Biospecimen Collection
Undergo blood sample collection
Ceralasertib
Given PO
Computed Tomography
Undergo CT or PET/CT
Echocardiography Test
Undergo ECHO
Multigated Acquisition Scan
Undergo MUGA
Positron Emission Tomography
Undergo PET/CT
Trastuzumab Deruxtecan
Given IV
RECRUITING
NYP/Weill Cornell Medical Center, New York
RECRUITING
Thomas Jefferson University Hospital, Philadelphia
ACTIVE_NOT_RECRUITING
National Cancer Institute Developmental Therapeutics Clinic, Bethesda
ACTIVE_NOT_RECRUITING
National Institutes of Health Clinical Center, Bethesda
RECRUITING
University of Florida Health Science Center - Gainesville, Gainesville
RECRUITING
Ohio State University Comprehensive Cancer Center, Columbus
RECRUITING
Memorial Hospital East, Shiloh
RECRUITING
Washington University School of Medicine, St Louis
RECRUITING
Siteman Cancer Center-South County, St Louis
RECRUITING
Siteman Cancer Center at Christian Hospital, St Louis
RECRUITING
Siteman Cancer Center at West County Hospital, Creve Coeur
RECRUITING
Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
RECRUITING
University of Oklahoma Health Sciences Center, Oklahoma City
RECRUITING
UT Southwestern/Simmons Cancer Center-Dallas, Dallas
RECRUITING
M D Anderson Cancer Center, Houston
RECRUITING
University of Texas at Austin, Austin
RECRUITING
Huntsman Cancer Institute/University of Utah, Salt Lake City
RECRUITING
Los Angeles General Medical Center, Los Angeles
RECRUITING
USC / Norris Comprehensive Cancer Center, Los Angeles
RECRUITING
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
RECRUITING
UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
RECRUITING
University of California Davis Comprehensive Cancer Center, Sacramento
RECRUITING
University of Texas Medical Branch, Galveston
National Cancer Institute (NCI)
NIH